Neuroradiologische Klinik, Klinikum Stuttgart, Stuttgart, Germany.
Medizinische Fakultät, Universität Duisburg-Essen, Essen, Germany.
Clin Neuroradiol. 2023 Jun;33(2):415-425. doi: 10.1007/s00062-022-01222-6. Epub 2022 Oct 20.
In elective carotid artery stenting (CAS), antiplatelet therapy (APT) is crucial. Several international societies have provided guidelines for loading time and dosage in endovascular treatment; however, no recommendations have been made for urgent, nonthrombectomy-associated CAS without adequate loading time. Here, we investigated the short-term outcomes for APT-naïve patients receiving "crash loading" (CL) on the day of intervention, compared with those for patients wi APT onset 3-5 days (semi-CL) or more than 5 days before CAS (EL).
Outcomes of patients 30 days after CAS were evaluated in terms of the rates of in-stent thrombus, re-stenosis, stroke, hemorrhagic and thrombotic events, other periprocedural occurrences, in-hospital death and CAS-associated death. Patients' biological, pathological and hemostatic factors were recorded and compared.
A total of 1158 patients who received CAS at the authors' neuroradiology institution were analyzed: 275 EL, 846 semi-CL, and 37 CL. The patients receiving CL had the lowest rate of stroke, but the highest rates of CAS-associated and in-hospital deaths, although the deaths were not necessarily associated with APT. In-stent thrombosis was the highest in the semi-CL group. The rates and types of periprocedural occurrences favored the CL group.
With the medical regimen used in this study, urgent CAS with CL APT did not produce more ischemic, thrombotic and hemorrhagic complications than longer loading times. However, careful patient selection might be crucial and adequate loading times should remain the standard of care.
在择期颈动脉支架置入术(CAS)中,抗血小板治疗(APT)至关重要。一些国际协会已经为血管内治疗的加载时间和剂量提供了指南;然而,对于没有足够加载时间的紧急、非血栓切除术相关的 CAS,尚未提出建议。在这里,我们研究了在介入当天接受“紧急加载”(CL)的 APT 初治患者与 APT 起始时间为 3-5 天(半 CL)或 5 天以上的患者(EL)的短期结果。
评估了 CAS 后 30 天患者的支架内血栓形成、再狭窄、中风、出血和血栓事件、其他围手术期事件、住院期间死亡和 CAS 相关死亡的发生率。记录并比较了患者的生物学、病理学和止血因素。
作者神经放射学机构共分析了 1158 例接受 CAS 的患者:275 例 EL、846 例半 CL 和 37 例 CL。接受 CL 的患者中风发生率最低,但 CAS 相关和住院期间死亡率最高,尽管这些死亡不一定与 APT 相关。支架内血栓形成在半 CL 组最高。围手术期事件的发生率和类型有利于 CL 组。
在本研究中使用的治疗方案中,紧急 CAS 与 CL APT 并不会比更长的加载时间产生更多的缺血、血栓和出血并发症。然而,仔细的患者选择可能至关重要,足够的加载时间仍应是标准的治疗方法。